Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer

Huiyuan Wang, Feng Li, Chengan Du, Huixin Wang, Ram I. Mahato, Yongzhuo Huang

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds